-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

613. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster III

Symposia: Acute Myeloid Leukemias: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Monday, December 11, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Michael Sandhu, MD1, Prashanth Ashok Kumar, MBBS2, Vishnu Suresh Kumar, MBBS3*, Osama Batayneh, MD4, Sravanthi Venkata Metpalli, MD4* and Teresa Gentile, MD, PhD4

1Department of Medicine, SUNY Upstate Medical University, Syracuse, NY
2Upstate Cancer Center, Division of Hematology/Oncology, SUNY Upstate Medical University, SYRACUSE, NY
3Division of Gastroenterology, SUNY Upstate Medical University, Syracuse, NY
4Upstate Cancer Center, Division of Hematology/Oncology, SUNY Upstate Medical University, Syracuse, NY

Philip A Haddad, MD1 and Shiva Jashwanth Gaddam, MD2

1Feist-Weiller Cancer Center, LSUHSC-S/Overton Brooks VAMC, Shreveport, LA
2Department of Hematology and Oncology and Feist Weiller Cancer Center, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA

Avraham Frisch, MD1*, Chezi Ganzel, MD2*, Yishai Ofran, MD3, Baher Krayem, MD1*, Vladimir Vainstein, MD4*, Arnon Haran5* and Boaz Nachmias, MD, PhD6*

1Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
2Shaare Zedek Medical Center, Jerusalem, Israel
3Department of Hematology, Shaare Zedek Medical Center, Faculty of Medicine Hebrew University of Jerusalem, Jerusalem, Israel
4Hadassah-Hebrew University medical center, department of hematology, Israel, Jerusalem, Israel
5Department of Hematology, Hadassah Hebrew University Medical Center, Jerusalem, Israel
6Department of Hematology, Hadassah Medical Center, Hebrew University Medical Faculty, Jerusalem, Israel

Chantana Polprasert, MD1*, Chantiya Chanswangphuwana, MD2*, Weerapat Owattanapanich3*, Smith Kungwankiattichai, MD4*, Ekarat Rattarittamrong, M.D.5*, Thanawat Rattanathammethee, MD6*, Wasithep Limvorapitak, MD7*, Supawee Saengboon8*, Pimjai Niparuck9*, Teeraya Puavilai, MD10*, Jakrawadee Julamanee, MD, PhD11, Pirun Saelue, MD12*, Chinadol Wanitpongpun, MD13*, Chajchawan Nakhakes, MD, MSc14*, Kannadit Prayongratana15*, Chantrapa Sriswasdi, MD16* and Adisak Tantiworawit, MD5

1Division of Hematology and Excellence Center in Translational Hematology, Faculty of Medicine, Chulalongkorn University, Bangkok, Bangkok, Thailand
2Division of Hematology and Excellence Center in Translational Hematology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
3Siriraj Hospital, Bangkok, THA
4Siriraj Hospital, Mahidol University, Bangkok, BKK, Thailand
5Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
6Chiang Mai University, Maung, Chiang Mai, Thailand
7Thammasat University, Pathumthani, Thailand
8Thammasat University, Pathum Thani, THA
9RAMATHIBODI HOSPITAL, Bangkok, THA
10Mahidol University and Ramathibodi Hospital, Bangkok, Thailand
11Prince of Songkla University, Songkhla, Thailand
12Prince of Songkla University, Songkla, THA
13Srinagarind Hospital, Thailand, AK, THA
14Rajavithi Hospital, Bangkok, THA
15Phramongkutklao Hospital and College of Medicine, BKK, Thailand
16Phramongkutklao Hospital and College of Medicine, Bangkok, THA

Maymona Abdelmagid1*, Kaaren K. Reichard, MD2, Omer Karrar3*, Rong He, MD2, Patricia Greipp, DO2, Rhett Ketterling, MD4, Mithun V Shah, MD, PhD3, Devendra Hiwase, MD, MBBS, PhD, FRACP, FRCPA5, Attilio Orazi, MD6*, Daniel A. Arber, MD7, Naseema Gangat, MBBS3 and Ayalew Tefferi, MD3

1Division of Hematology, Mayo Clinic, Rochester, MN, USA., Rochester, MN
2Division of Hematopathology, Mayo Clinic, Rochester, MN
3Division of Hematology, Mayo Clinic, Rochester, MN
4Mayo Clinic, Rochester, MN
5Walter and Eliza Hall Institute of Medical Research, Adelaide, SA, Australia
6Texas Tech University Health Sciences Center, El Paso
7University of Chicago, Chicago, IL

Francesco Mannelli, MD1*, Matteo Piccini2*, Marco Frigeni, MD3*, Giacomo Gianfaldoni4*, Sara Bencini5*, Silvia Salmoiraghi3*, Barbara Scappini6*, Benedetta Peruzzi7*, Roberto Caporale7*, Gaia Ciolli2*, Laura Fasano2*, Francesca Crupi2*, Elisa Quinti2*, Andrea Pasquini2*, Sofia Pilerci, MD8*, Fiorenza Vanderwert9*, Giada Rotunno10*, Fabiana Pancani11*, Leonardo Signori11*, Danilo Tarantino12*, Chiara Maccari10*, Vivian Paradiso2*, Francesco Annunziato7*, Orietta Spinelli13*, Paola Guglielmelli, MD, PhD14, Alessandro Rambaldi, M.D.15 and Alessandro Maria Vannucchi16

1CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
2SOD Ematologia, Università di Firenze, AOU Careggi, Firenze, Italy
3Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy, Bergamo, Italy
4Hematology Unit, AOU Careggi, Florence, Italy
5Centro Diagnostico di Citofluorimetria e Immunoterapia, AOU Careggi, Florence, Italy
6Azienda Ospedaliero-Universitaria Careggi, Florence, ITA
7Centro Diagnostico di Citofluorimetria e Immunoterapia, AOU Careggi, Firenze, Italy
8Hematology Unit, Careggi Hospital, Firenze, Italy
9SOD Ematologia, Università di Firenze, AOU Careggi, Firenze, Italy; Centro Ricerca e Innovazione Malattie Mieloproliferative (CRIMM), Firenze, Italy
10Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
11Centro Ricerca e Innovazione Malattie Mieloproliferative (CRIMM), AOU Careggi, Firenze, Italy
12Department of Experimental and Clinical Medicine, Centro di Ricerca e Innovazione Malattie Mieloproliferative (CRIMM), AOU Careggi, University of Florence, Florence, Italy
13Hematology and Bone Marrow Transplant Unit, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
14CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy
15Department of Oncology and Hematology, University of Milan and Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo BG, Italy
16Department of Experimental and Clinical Medicine, Centro di Ricerca e Innovazione Malattie Mieloproliferative (CRIMM), AOU Careggi, University of Florence, Firenze, Italy

Chao-Ling Wan1*, Yuan-Hong Huang1*, Si-Man Huang1*, Tong-Tong Zhang1*, Kai-Wen Tan1*, Yan Qiu1*, Xiang-Dong Shen1*, Shuai-Shuai Ge1*, Han-Yu Cao1*, Yan-Yan Li1*, Songbai Liu2*, Qiao-Cheng Qiu1*, Haiping Dai1* and Sheng-Li Xue1*

1Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China
2Suzhou Vocational Health College, Suzhou, CHN

Evangelia Antoniou, MD1*, Annika Puschnig2*, Lina Marie Hoffmeister2*, Amani Awada2*, Nils Von Neuhoff, PhD1*, Markus Schneider, PhD2*, Dirk Reinhardt, MD2 and Naghmeh Niktoreh, MD2*

1University Children’s Hospital Essen. Department of Pediatric Hematology and Oncology, Essen, Germany
2Department of Pediatrics III, University Children’s Hospital Essen, University of Duisburg-Essen, Essen, Germany

Bozena Katarzyna Budziszewska, MD, PhD1*, Michał Łomiak, MD1*, Joanna Barankiewicz, MD, PhD1*, Elzbieta Patkowska, MD, PhD1*, Grzegorz Helbig, MD, PhD2*, Lukasz Bolkun, MD, PhD3*, Anna Irga-Staniukiewicz, MD4*, Anna Kiżewska4*, Agnieszka Piekarska, MD, PhD4*, Anna Koclęga, MD2*, Agnieszka Pluta, MD, PhD5*, Marta Kuydowicz, MD5*, Sylwia Kościółek- Zgódka, MD6*, Edyta Cichocka, MD, PhD7*, Agata Malenda, MD, PhD8*, Karol Wójcik, MD9*, Tomasz Gromek, MD, PhD10*, Piotr Małecki, MD11*, Sebastian Grosicki, MD, PhD11*, Agnieszka Wierzbowska, M.D., Ph.D.12 and Ewa Lech-Maranda, MD, PhD13*

1Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
2Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland
3Medical University of Bialystok, Bialystok, Poland
4Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland
5Department of Hematology and Transplantology, Copernicus Memorial Hospital in Lodz, Department of Hematology, Medical University of Lodz, Lodz, Poland
6Holy Cross Cancer Center, Kielce, Poland
7Nicolaus Copernicus General Hospital, Torun, Poland
8Faculty of Medicine, Lazarski University, Warsaw, Poland
9Hematology Department, Rydygier Memorial Hospital, Krakow, Poland
10Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland
11Department of Hematology and Cancer Prevention, Faculty of Health Sciences, Medical University of Silesia, Katowice, Poland
12Department of Hematology and Transplantology, Multidisciplinary Provincial Centre of Traumatology and Oncology Nicolas Copernicus in Lodz, Lodz, Poland
13Institute of Hematology and Transfusion Medicine, Warsaw, Poland

Phyu Thin Naing, MBBS1, Stephanie Boisclair, MD2, Edward Zhou, MD1, Richa Thakur, MD3, Erin Jou, MD4, Bradley Goldberg, MD4, David W Chitty, DO, MSc5 and Jonathan E Kolitz, MD6

1Zuckerberg Cancer Center, New Hyde Park, NY
2Northwell Health, Zuckerberg Cancer Center, Lake Success, NY
3Zuckerberg Cancer Center, New Hyde Park
4Zuckerberg Cancer Center, Lake Success, NY
5Zuckerberg Cancer Center, Northwell Health, New Hyde Park, NY
6Northwell Cancer Center, Hofstra/Northwell School of Medicine, Lake Success, NY

Jeremy S Connors, MD1, Linda Zhang, BA2*, Koji Sasaki, MD3, Courtney D. DiNardo, MD, MSc4, Nicholas J. Short, MD4, Naval Daver, MD4, Gautam Borthakur, MD4, Tapan M. Kadia, MD4, Hagop Kantarjian, MD5, Elias Jabbour6, Margaret A Goodell, PhD7*, Guillermo Garcia-Manero, MD8 and Koichi Takahashi, MD, PhD4

1Pediatric Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Hospital, Houston, TX
2Baylor College of Medicine, Houston, TX
3Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
5The University of Texas MD Anderson Cancer Center, Houston, TX
6University of Texas M.D. Anderson Cancer Ctr., Houston, TX
7Center For Cell and Gene Therapy, Houston, TX
8University of Texas MD Anderson Cancer Center, Houston, TX

Baher Krayem, MD1*, Tsila Zuckerman, MD2,3, Avraham Frisch, MD3*, Ilana Slouzkey4*, Tehila Azoulay4*, Michal Karmona4*, Liran I. Shlush, MD, PhD5*, Nathali Kaushansky, PhD5*, Noa Chapal-Ilani5* and Shimrit Ringelstein-Harlev3*

1Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Rappaport Faculty of Medicine - Technion, Haifa, Israel
2The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
3Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
4Hematology Laboratory, Rambam Health Care Campus, Haifa, Israel
5Department of Immunology, Weizmann Institute of Science, Rehovot, Israel

Hyun-Young Kim, MD1*, Boram Kim1*, Jayoung Lee, MD2*, Shinae You, MD2*, In-Suk Kim, MD3, Hyerin Kim, MD4*, Hyerim Kim, MD4*, Jee-Soo Lee, MD5*, Yoon Hwan Chang, MD, PhD5*, Hyunkyung Kim, MD, PhD5*, Saeam Shin6*, Yu Jeong Choi6*, Miyoung Kim, M.D., Ph.D.7*, Young-Uk Cho, M.D., Ph.D.7*, Seongsoo Jang, M.D., Ph.D.7, Byunggyu Bae8*, Jong-Mi Lee8*, Yonggoo Kim8* and Myungshin Kim8*

1Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
2Department of Laboratory Medicine, Inje University College of Medicine, Busan, Korea, Republic of (South)
3Department of Laboratory Medicine, Pusan National University School of Medicine, Yangsan, Yangsan, South Korea
4Department of Laboratory Medicine, Pusan National University School of Medicine, Yangsan, Korea, Republic of (South)
5Department of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea, Republic of (South)
6Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of (South)
7Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
8Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)

David Martinez-Cuadron, PhD1*, Blanca Boluda2*, Jesús Lorenzo Algarra3*, Juan Miguel Bergua Burgues4*, Rebeca Rodriguez Veiga, MD5*, Pilar Martinez Sanchez, M.D.6*, Josefina Serrano, MD7*, Fernando Jesús Ramos-Ortega, MD8*, Jose A. Pérez-Simón9, Mar Tormo, M.D.10, Jose Luis Lopez Lorenzo, MD11*, Esperanza Lavilla12*, Teresa Bernal Del Castillo, MD, PhD13*, Carlos Rodríguez-Medina, MD, PhD14*, Maria Carmen GARCIA Garay15*, Maria Jose Sayas Lloris16*, Cristina Gil, MD17*, Maria Teresa Olave Rubio18*, Raimundo Garcia Boyero19*, Susana Vives20*, Maria Angeles Foncillas21*, Jorge Labrador22*, Francisco Ibañez23*, Ana Cabello24*, Pilar Herrera Puente25*, Bernardo Javier González González, MD26*, Eva Barragán, PhD27*, Claudia Sargas28*, Rosa Ayala, MD29*, Carmen Chillon30* and Pau Montesinos, PhD, MD31*

1Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
2Hospital Universitari I Politècnic La Fe, Valencia, ESP
3Hospital General de Albacete, Albacete, ESP
4Hospital San Pedro de Alcántara, Caceres, Spain
5Hospital Universitary i Politecnic La Fe, VALENCIA, ESP
6Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
7Hospital Universitario Reina Sofía, IMIBIC, Cordoba, ESP
8Hospital Universitario de León, León, Spain
9Instituto de Biomedicina de Sevilla (IBIS), Servicio de Hematología, Hospital Universitario Virgen del Rocío and Consejo Superior de Investigaciones Científicas (CSIC), Universidad de Sevilla, Sevilla, Spain
10Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain
11Fundacion Jimenez Diaz, Madrid, ESP
12Hospital Universitario Lucus Augusti, Lugo, Spain
13Hospital Universitario Central de Asturias, Oviedo, Spain
14Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas, ESP
15Hospital Universitario Virgen de la Arrixaca, Murcia, Spain
16Hospital Dr. Peset, ZARAGOZA, ESP
17Hospital General Universitario de Alicante, Alicante, ESP
18Hospital Clinico Universitario Lorenzo Blesa, Zaragoza, ESP
19Hospital General Universitario de Castellon, Castellon, Spain
20Hospital Germans Trias i Pujol, Badalona, ESP
21Hospital Universitario Infanta Leonor, Madrid, ESP
22Hospital Universitario de Burgos, Universidad Isabel I, Burgos, ESP
23Hospital General Universitario de Valencia, Valencia, Spain
24Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz De Tenerife, ESP
25Hospital Universitario Ramon y Cajal, Madrid, ESP
26Hospital Universitario de Canarias, Tenerife, Spain
27Molecular Biology Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain
28Hospital La Fe, Valencia, ESP
29Hospital Universitario 12 de Octubre, Madrid, Spain
30Department of Hematology, Hospital Universitario de Salamanca-IBSAL, Salamanca, Spain
31Hospital Universitari i Politecnic la Fe, Valencia, Spain

Francesca Crupi1*, Gaia Ciolli1*, Matteo Piccini, MD1*, Sara Bencini2*, Giacomo Gianfaldoni3*, Benedetta Peruzzi4*, Roberto Caporale4*, Barbara Scappini1*, Laura Fasano1*, Elisa Quinti1*, Andrea Pasquini1*, Jessica Caroprese1*, Fabiana Pancani1,5*, Leonardo Signori1,5*, Chiara Maccari6,7*, Vivian Paradiso1*, Francesco Annunziato4*, Paola Guglielmelli, MD, PhD1,8, Alessandro Maria Vannucchi1,9 and Francesco Mannelli1,9*

1SOD Ematologia, Università di Firenze, AOU Careggi, Firenze, Italy
2Centro Diagnostico di Citofluorimetria e Immunoterapia, AOU Careggi, Florence, Italy
3AOU Careggi, Florence, Italy
4Centro Diagnostico di Citofluorimetria e Immunoterapia, AOU Careggi, Firenze, Italy
5Centro Ricerca e Innovazione Malattie Mieloproliferative (CRIMM), AOU Careggi, Firenze, Italy
6Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
7CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
8Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
9CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy

Helena Pomares, MD, PhD1*, Iago Arribas, MD2*, Teresa Quiñones, MD2*, Jasson Villarreal Hernandez2*, Julia Ribes Amoros, MD2*, Clara Maluquer Artigal, MD3*, Shiomara Quiñones, MD2*, Maria Isabel Sotelo, MD2*, María Alicia Senin, MD, PhD4*, Mercedes Galiano2*, Enric Gamundi, MD5*, Lurdes Zamora, PhD6*, Neus Ruiz Xiville, PhD7*, Anna Maria Sureda Balari, MD, PhD8 and Montserrat Arnan Sangerman, MD, PhD9*

1Hematology Department. Institut Català d’Oncologia, Hospital Duran i Reynals. Institut d’Investigació Biomèdica de Bellvitge (IDIBELL). Universitat de Barcelona., Barcelona, Spain
2Hematology Department. Institut Català d’Oncologia, Hospital Duran i Reynals. Institut d’Investigació Biomèdica de Bellvitge (IDIBELL). Universitat de Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
3Hematology Department. Institut Català d’Oncologia, Hospital Duran i Reynals. Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain
4Institut Català d’Oncologia, Hospital Duran i Reynals. Institut d’Investigació Biomèdica de Bellvitge (IDIBELL). Universitat de Barcelona, Barcelona, Spain
5Department of Pathology. Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain
6Hematology Department, Institut Català d’Oncologia - Hospital Universitari Germans Trias i Pujol, Institut de Recerca Contra la Leucèmia Josep Carreras, Universitat Autònoma de Barcelona, Badalona, Spain
7Hematology Department. Institut Català d’Oncologia, Hospital Universitari Germans Trias i Pujol. Institut Josep Carreras, Badalona. Barcelona, Spain
8Institut Catala D'Oncologia, Barcelona, Spain
9Hematology Department. Institut Català d’Oncologia, Hospital Duran i Reynals. Institut d’Investigació Biomèdica de Bellvitge (IDIBELL). Universitat de Barcelona, Hospitalet de Llobregat, Barcelona, Spain

Enbo Chen1*, Jian Ge, PhD2*, Changqing Jiao2*, Jian Yu2* and Zhonghui Wu2*

1Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, AL, China
2Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, China

Jayanshu Jain, MD1, Kenneth P Byrd, DO1, Heather J Male, MD1, Haitham Abdelhakim, MD2, Jesus D Gonzalez-Lugo, MD3 and Tara L Lin, MD4

1Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
2University of Kansas Medical Center, Westwood, KS
3Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS
4Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Medical Center, Westwood, KS

Alex Bataller, MD, PhD1*, Alexandre Bazinet, MD2*, Courtney D. DiNardo, MD, MSc1, Gautam Borthakur, MD1, Nicholas J. Short, MD1, Elias Jabbour3, Koichi Takahashi, MD, PhD1, Naval Daver, MD1, Ghayas C. Issa4, Naveen Pemmaraju, MD1, Nitin Jain, MD1, Guillermo Montalban-Bravo, MD1, William G. Wierda, MD, PhD4, Guillermo Garcia-Manero, MD5, Farhad Ravandi, MD, MBBS1, Hagop M. Kantarjian, MD1 and Tapan M. Kadia, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, MD Anderson Cancer Center, Houston, TX
3University of Texas M.D. Anderson Cancer Ctr., Houston, TX
4The University of Texas MD Anderson Cancer Center, Houston, TX
5University of Texas MD Anderson Cancer Center, Houston, TX

Pranavi Sanka, MD1*, Pamela Egan, MD2, Rabin Niroula, MBBS3, Inna Yakirevich, NP4*, David Gardner, MSN, NP4* and John L. Reagan, MD5

1Lifespan, Alpert Medical School of Brown University, Providence, RI
2Lifespan Cancer Institute, Legoretta Cancer Center of Brown University, Providence, RI
3Lifespan Cancer Institute, Legorreta Cancer Center of Brown University, Providence, RI
4Lifespan Cancer Institute, Providence, RI
5Legorreta Cancer Center of Brown University, Providence, RI

Carlos Jimenez-Vicente, MD1*, Paola Charry, MD2*, Maria Suarez-Lledo, MD, PhD3*, Beatriz Merchán Muñoz, MD2*, Sandra Castaño-Díez, MD1*, Amanda Isabel Perez-Valencia4*, Alexandra Martínez-Roca, MD4*, Francesca Guijarro, MD5*, Mònica López-Guerra6*, Albert Cortés-Bullich, MD4*, Daniel Esteban3*, Ares Guardia-Torrelles4*, Ines Zugasti4*, Daniel Munárriz, MD3*, Laura Rosiñol, MD, PhD2*, Alvaro Urbano-Ispizua Sr., MD2, Francesc Fernández-Avilés, MD3*, Carmen Martinez, MD, PhD3*, Marina Díaz-Beyá, MD, PhD1*, Montserrat Rovira, MD, PhD3*, Maria Queralt Salas2* and Jordi Esteve, MD, PhD1

1Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain
2Hematopoietic Cell Transplantation Unit, Hospital Clínic de Barcelona, ICHMO, Barcelona, Spain
3Hospital Clínic de Barcelona, Barcelona, Spain
4Hematology Department, Hospital Clinic de Barcelona, ICMHO, Barcelona, Spain
5Hematopathology Unit, Pathology Department, Hospital Clínic de Barcelona, Barcelona, Spain
6Hematopathology Section, Pathology Department, Hospital Clínic Barcelona, Barcelona, Spain

Maria Moscvin, MD1*, Matthew Schwede, MD2, Gabriel N. Mannis2,3,4 and Tian Y. Zhang, MD, PhD2,5,6

1Stanford Healthcare, Palo Alto, CA
2Division of Hematology, Department of Medicine, Stanford University, Stanford, CA
3Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA
4Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA
5Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
6Stanford Cancer Institute, Stanford, CA

Marco Frigeni, MD1*, Leonardo Gerosa2*, Chiara Pavoni3*, Tamara Intermesoli1*, Giulia Quaresmini1*, Marta Bellini1*, Marta Castelli4*, Clara Belotti5*, Martina Milani1*, Silvia Salmoiraghi5*, Orietta Spinelli1*, Fabio Lorenzano2*, Alessandro Putelli2*, Monica Galli1*, Federico Lussana, MD, PhD1,2* and Alessandro Rambaldi, M.D.1,6

1Hematology and Bone Marrow Transplant Unit, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
2Department of Oncology and Hematology, University of Milan, Milan, Italy
3Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
4Department of Oncology and Hematology, University of Milan, Cassina De' Pecchi (milan), Italy
5FROM Research Foundation, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
6Department of Oncology and Hematology, University of Milan and Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo BG, Italy

Ian Bouligny, M.D.1, Graeme Murray, M.D., Ph.D.2*, Thuy Ho, M.D.2*, Juhi Gor, M.D.2*, Kyle Zacholski, Pharm.D.3*, Nolan Wages, Ph.D.4*, Steven Grant, M.D.2* and Keri Maher, DO5

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Massey Cancer Center, Virginia Commonwealth University, Richmond, VA
3Massey Cancer Center, Department of Pharmacy, Virginia Commonwealth University, Richmond, VA
4Massey Cancer Center, Department of Biostatistics, Virginia Commonwealth University, Richmond
5Massey Cancer Center, Virginia Commonwealth University, Tucson, AZ

Irene Navarro Vicente1,2*, Pilar Lloret Madrid1,2*, Antonio Solana-Altabella, PharmD2,3*, Pilar Martinez Sanchez, M.D.4*, Maria Angeles Foncillas5*, Carlos Cervero, MD6*, Victor Noriega7*, Maria Paz Garrastazul Sánchez8*, Jose Maria Alonso Alonso9*, Beatriz De Rueda Ciller10*, Pilar Herrera Puente11*, Susana Vives12*, Josefina Serrano, MD13*, Lourdes Hermosín, PhD14*, Fernando Jesús Ramos-Ortega, MD15*, Teresa Bernal16*, Jesús Lorenzo Algarra17*, Mercedes Colorado18*, Raimundo García-Boyero19*, Juan Miguel Bergua Burgues20*, Lisette Costilla-Barriga21*, Tamara Castaño, MD22*, Jorge Labrador23*, Armando Mena Duran24*, Maria Dolores Madrigal Toscano25*, Maria Del Mar Hermosilla-Fernandez26*, Carmen Couto27*, Esther Perez Santaolla, MD28*, Jose Mario Mariz, MD29, Sandra Casal Marini30*, Cristina Gil, MD31*, David Martinez-Cuadron, PhD1,2* and Pau Montesinos, PhD, MD1*

1Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
2Hematology Department, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain
3Pharmacy Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
4Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
5Hospital Universitario Infanta Leonor, Madrid, ESP
6Hospital Virgen de la Luz, Cuenca, Spain
7Hospital Clínico de A Coruña, A Coruña, Spain
8Hospital Universitario Puerta del Mar, Cádiz, Spain
9Hospital Rio Carrión, Palencia, Palencia, ESP
10Hospital Miguel Servet, Zaragoza, Spain
11Hospital Universitario Ramon y Cajal, Madrid, ESP
12Hospital Germans Trias i Pujol, Badalona, ESP
13Hospital Universitario Reina Sofía, IMIBIC, Cordoba, ESP
14Department of Hematology, Hospital Jerez de la Frontera, Jerez de la Frontera, Cádiz, Spain
15Hospital Universitario de León, León, Spain
16Hospital Universitario Central de Asturias, Instituto Universitario (IUOPA), Instituto de Investigación del Principado de Asturias (ISPA), Oviedo, Spain
17Hospital General de Albacete, Albacete, ESP
18Hospital Universitario Marqués De Valdecilla, Santander, Spain
19Hospital General De CastellóN, CastellóN, ESP
20Hospital San Pedro de Alcántara, Caceres, Spain
21Hospital San Jorge, Zaragoza, ESP
22Hospital Fundación Jiménez Díaz, Madrid, Spain
23Hospital Universitario de Burgos, Universidad Isabel I, Burgos, ESP
24Hospital General de Valencia, Valencia, ESP
25Hospital Universitario Virgen Macarena, Sevilla, ESP
26Hospital San Pedro, Logroño, ESP
27Hospital Virgen de Valme, Sevilla, ESP
28Hospital Donostia, Donostia, Spain
29Instituto Português Oncologia do Porto Francisco Gentil, Oporto, Portugal
30Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
31Hospital General Universitario de Alicante, Alicante, ESP

Gabriel Roman Souza, MD1, Kana Tai Lucero, MD2*, Ian Mines, DO2, Heidi Latiolais, MD, MSc2, Kathleen Franklin, RN3*, Michael Mader, MS3* and Zohra Nooruddin, MD4

1H. Lee Moffitt Cancer Center and Research Institute/University of South Florida Morsani, Tampa, FL
2University of Texas Health Science Center at San Antonio, San Antonio, TX
3South Texas Veterans Health Care System, San Antonio, TX
4University of Texas Health-San Antonio, San Antonio, TX

Naszrin Arani, MD1*, Emmanuel Almanza, MD2*, Alex Bataller, MD, PhD2*, Courtney D. DiNardo, MD, MSc2, Farhad Ravandi, MD, MBBS2, Naval Daver, MD2, Naveen Pemmaraju, MD3, Musa Yilmaz, MD2*, Abhishek Maiti, MD2, Patrick K Reville, MD, MPH2, Sanam Loghavi, MD4, Hussein A Abbas, MD, PhD2, Guillermo Garcia-Manero, MD5, Nicholas J. Short, MD2, Hagop M. Kantarjian, MD5 and Tapan M. Kadia, MD2

1Internal Medicine, Baylor College of Medicine, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, MD Anderson Cancer Center, Houston, TX
4Hematopathology, MD Anderson Cancer Center, Houston, TX
5University of Texas MD Anderson Cancer Center, Houston, TX

Yue Jin1*, Haixia Fu, MD2*, Yuhong Chen3*, Yuanyuan Zhang, MD4,5*, Jing-Zhi Wang6*, Xiao-Dong Mo, MD7*, Huan Chen8*, Yao Chen, MD1*, Yu Wang, MD6*, Ying-Jun Chang9*, Lanping Xu, MD10*, Kai-yan Liu, MD, PhD1, Xiao-Jun Huang, MD11* and Xiaohui Zhang, MD1,7,11*

1Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China., Beijing, China
2Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, Beijing, China
3Peking University People’s Hospital, BEIJING, CHN
4Peking University People’s hospital, Beijing, China
5Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China
6Peking University People’s Hospital, Beijing, China
7Peking University People's Hospital, Beijing, China
8Peking University,people's Hospital, Beijing, CHN
9Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
10Peking University People’s Hospital,Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China
11Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China

*signifies non-member of ASH